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Abstract
Background: In this study, we aimed to investigate the importance 
of the use of heart-type fatty acid binding protein (H-FABP) in 
evaluating the myocardial damage in patients admitted to the emer-
gency department with moderate to severe carbon monoxide (CO) 
poisoning.
Methods: All patients admitted to the emergency department with 
severe acute CO intoxication were enrolled the study. The H-FABP 
and cardiac biomarker levels were assessed at 0, 6th and 24th hours. 
The patients were divided into groups as those with normal echo-
cardiography ﬁ  ndings and with wall motion abnormalities. The dif-
ferences between the groups for these parameters were compared.
Results: The mean age of 80 patients was 32.3 ± 12.9 years old. 42 
of them were male. On admission, 29 (36.3%) had elevated serum 
troponin I levels and 56 (70.0%) had elevated serum H-FABP lev-
els. At 6thhour, 4 (5.0%) of 80 patients had higher serum H-FABP 
levels and 23 (28.8%) of them had higher serum Troponin I levels 
than 0 hour. The patients with wall motion abnormality had signiﬁ  -
cantly higher serum H-FABP levels compared to the patients with 
normal echocardiography ﬁ  ndings at 6th and 24th hours (p = 0.001 
and 0.009). While the serum COHb and H-FABP levels tended to 
decrease continuously in time (p < 0.001), the serum troponin I 
levels increased at 6th hour and then decreased at 24th hour (p = 
0.017).
Conclusions: The serum H-FABP levels are useful in identifying 
the myocardial damage in patients admitted to the emergency de-
partment with moderate to severe carbon monoxide poisoning at an 
early phase.
Keywords: Carbon monoxide; Poisoning; H-FABP; Myocardial 
injury
Introduction
Carbon monoxide (CO) is an odorless, colorless, tasteless, 
non-irritating gas formed as a by-product of burning organic 
compounds. The atmospheric concentration of CO is gener-
ally below 0.001%. The afﬁ  nity of hemoglobin for CO is 200 
to 250 times greater than its afﬁ  nity for oxygen. This results 
in competitive inhibition of oxygen release due to a shift in 
the oxygen-hemoglobin dissociation curve, reduced oxygen 
delivery, and subsequent tissue hypoxia [1-3].
The body relies on oxygen to reach the cells to function; 
therefore, all the body systems are affected by carbon mon-
oxide poisoning. The heart, the brain, and the lungs require 
continuously large amounts of oxygen for normal function 
and CO has its most profound impact on these vital organs, 
[2, 4-6]. Carbon monoxide poisoning has a variety of delete-
rious cardiac effects including arrhythmias, coronary spasm, 
ventricular dysfunction and myocardial infarction [7, 8]. 
There is only limited correlation between the carboxy-
hemoglobin (COHb) level and the severity of clinical fea-
tures [9]. Patients with pre-existing disease can experience 
increased exertional angina with COHb levels as low as 
5-10%. At high COHb levels, even young healthy patients 
develop myocardial depression [10]. Recent studies sug-
gest that a baseline electrocardiogram (ECG) should be per-
formed and serial biomarkers should be followed¬-up in all 
patients with CO intoxication to determine the degree and 
duration of cardiac damage or dysfunction. Furthermore, pa-
tients with abnormal cardiac biomarkers should undergo an 
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echocardiogram [7, 11, 12]. 
The heart-type fatty acid binding protein (H-FABP) is 
one of the most abundant proteins in the heart. H-FABP is 
a low molecular weight protein that behaves similarly to 
myoglobin in its kinetics and release. However, in contrast 
to myoglobin, there is more fatty acid binding proteins in 
the heart compared to skeletal muscle. It is more speciﬁ  c 
than myoglobin and it can be identiﬁ  ed earlier than creat-
inin kinase MB (CK-MB) and troponins in acute coronary 
syndrome [13-16]. It has been reported in few clinical and 
experimental studies recently that H-FABP levels are useful 
in identifying the cardiotoxicity of carbon monoxide intoxi-
cations at an early phase [12, 17].
In this study, we aimed to investigate the importance of 
the use of H-FABP in evaluating the myocardial damage in 
patients admitted to the emergency department with moder-
ate to severe carbon monoxide poisoning.
Methods
This prospective study was conducted, beginning from April 
2008 to December 2010 in the intensive care unit of Konya 
Training and Research Hospital, Emergency Medicine De-
partment. All patients (15 years of age and older) admitted 
to the emergency department with severe acute CO intoxica-
tion (COHb levels > 25%) were enrolled in the study.  
The demographic characteristics of patients such as age 
and gender were recorded. Blood samples were collected on 
admission (hour 0) to the emergency department. For analy-
sis of serum COHb, H-FABP, CK-MB and troponin I levels, 
5 ml samples of venous blood drawn into vaccutainer tubes 
and heparinized syringes. 12-derivation electrocardiograms 
were performed on all patients on admission. Blood sam-
pling and electrocardiograms were repeated at the 6th and 
the 24th hours for analysis of serum COHb, H-FABP, CK-
MB, troponin I levels and electrocardiogram ﬁ  ndings.
COHb levels were measured by a blood gas analyzer 
(Rapidlab® 1265) that was supported by a CO-oximetry pan-
el developed by Siemens Healthcare Diagnostics. We used a 
sandwich enzyme-linked immunosorbent assay (ELISA) for 
the determination of human H-FABP (Cardiodetect®). The 
rapid H-FABP test was calibrated to detect a serum H-FABP 
concentration of > 7.0 ng/mL as a positive line. An auto-
matic autoanalyzer was used in the biochemistry laboratory 
for determination of CK-MB and troponin I levels. Levels > 
25 U/L for CK-MB and > 0.2 ng/mL for troponin I were ac-
cepted as indicating myocardial damage.
Electrocardiograms were classiﬁ  ed by rhythm and ST-T 
wave changes. Continuous ECG monitoring was performed 
on patients with chest pain, dyspnea, or ECG changes. Echo-
cardiographies were performed and classiﬁ  ed by wall mo-
tion abnormalities. Coronary angiography was performed on 
patients with ischemic ECG ﬁ  ndings and elevated Troponin 
I levels at the 24th hour. 
All the patients were conventionally treated using high-
ﬂ  ow normobaric oxygen and monitored under intensive care 
conditions. All the patients were followed-up until the serum 
COHb levels decreased below 5% and their clinical ﬁ  ndings 
such as headache, nausea, and vomiting disappeared. 
Descriptive statistics were computed for age and gender. 
The data were expressed as mean ± SD. The differences in 
the means and the changes of the variables were tested using 
the Paired t test and the Student’s t test. The patients were 
divided into groups of those with normal echocardiography 
ﬁ  ndings and those with wall motion abnormalities. For each 
group, the mean COHb, H-FABP, CK-MB, troponin I levels 
were computed for the 0 hour, 6th hour and the 24th hour. 
The differences between the groups for these parameters 
were compared using the Mann-Whitney U test. The rela-
tionship between COHb, H-FABP and troponin I levels was 
assessed using the Pearson correlation analysis. A p value of 
< 0.05 was accepted as statistically signiﬁ  cant. The analy-
sis of the data was performed using the SPSS version 16.0 
(SPSS, Chicago, IL).
This study was conducted in accordance with the re-
quirements of local ethical committee and was in compliance 
with the Helsinki Declaration.
Results
A total of 80 patients were enrolled in the study during the 
study period. The mean age of patients was 32.3 ± 12.9 years. 
42 (52.5%) of the 80 patients were male and 38 (47.5%) were 
female. The mean COHb levels were 39.7 ± 9.9% at hour 0, 
8.2 ± 3.7% at the 6th hour and 1.5 ± 2.0% at the 24th hour. 
The COHb levels tended to decrease continuously at 0 hours, 
6th hour and 24th hour, and this decrease was signiﬁ  cant (p 
< 0.001).
On admission, 33 (41.2%) of the 80 patients had nor-
mal electrocardiograms. Sinus tachycardia was present in 
39 (48.8%) of the 80 patients. 4 (5%) of them had ischemic 
changes, 3 (3.8%) had sinus arrhythmia, and 1 (1.2%) had 
ventricular extrasystole. At hour 6, 66 (82.5%) of the 80 pa-
tients had normal ECG and 75 (93.8%) of them had normal 
ECG at the 24th hour.  
On admission, 23 (%28.8) of the 80 patients had elevat-
ed serum CK-MB levels (50.39 ± 42.64 U/L), 29 (36.3%) 
had elevated serum troponin I levels (0.71 ± 0.70 ng/mL), 
and 56 (70.0%) had elevated serum H-FABP levels (41.65 ± 
20.35 ng/mL). At the 6th hour, 35 (43.8%) of the 80 patients 
had elevated serum CK-MB levels (47.17 ± 32.58 U/L), 33 
(41.2%) had elevated serum troponin I levels (0.99 ± 1.26 
ng/mL), and 35 (43.8%) had elevated serum H-FABP lev-
els (30.34 ± 23.93 ng/mL). At the 24th hour, 27 (33.8%) of 
the 80 patients had elevated serum CK-MB levels (46.37 ± 
26.39 U/L), 31 (38.8%) had elevated serum troponin I levels 
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(0.78 ± 1.04 ng/mL), and 19 (23.8%) had elevated serum 
H-FABP levels (27.09 ± 29.32 ng/mL). At the 6th hour, 4 
(5.0%) of the 80 patients had higher serum H-FABP levels 
than at 0 hour, and 23 (28.8%) of them had higher serum 
troponin I levels than at 0 hour. 
Echocardiography was performed on 53 (66.3%) of the 
80 patients. Those 53 patients were divided into 2 groups 
according to echocardiography ﬁ  ndings. 41 (51.3%) of them 
had normal echocardiography ﬁ   ndings (Group I) and 12 
(15%) of them had wall motion abnormalities (Group II). 
There was no statistically signiﬁ   cant difference between 
the groups in terms of serum COHb levels at 0 hour, 6th 
hour and the 24th hour (p > 0.05). There was no statistically 
signiﬁ  cant difference between the groups in terms of serum 
Figure 1. The changes in time in serum H-FABP levels.
Group I
Normal echocardiography ﬁ  ndings
(n = 41)  (mean ± SD)
Group II
Wall motion abnormalities
(n = 12) (mean ± SD)
p value
COHb (%)
    Hour 0 39.57 ± 10.49 41.98 ± 12.79 p > 0.05
    Hour 6 7.69 ± 3.26 7.83 ± 3.89  p > 0.05
    Hour 24  1.24 ± 0.66 1.06 ± 0.65 p > 0.05
H-FABP (ng/mL)
    Hour 0 33.05 ± 23.73 41.17 ± 23.66 p > 0.05
    Hour 6 12.37 ± 18.91 37.75 ± 31.99 p = 0.001
    Hour 24  4.73 ± 11.56 24.75 ± 37.56 p = 0.009
Troponin I (ng/mL)
    Hour 0 0.25 ± 0.41 0.89 ± 0.93 p = 0.002
    Hour 6 0.30 ± 0.43 1.69 ± 1.85 p = 0.003
    Hour 24  0.25 ± 0.30 1.25 ± 1.57 p = 0.001
CK-MB (U/L)
    Hour 0 22.24 ± 13.99 57.58 ± 59.12 p = 0.002
    Hour 6 26.24 ± 14.46 67.08 ± 47.49 p < 0.001
    Hour 24  23.15 ± 14.79 51.08 ± 38.20 p = 0.002
Table 1. Comparison of the Patients With Normal Echocardiography Findings and With Wall Motion Abnormalities
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H-FABP levels at 0 hour (p>0.05). However, the patients 
with wall motion abnormality had signiﬁ  cantly higher se-
rum H-FABP levels compared to the patients with normal 
echocardiography ﬁ  ndings at the 6th hour and the 24th hour 
(respectively, p = 0.001 and 0.009) (Table 1).
The serum COHb and H-FABP levels tended to de-
crease continuously at 0 hour, 6th hour and 24th hour in both 
groups and this decrease was signiﬁ  cant (group I, for both p 
< 0.001 and group II, respectively p < 0.001 and p = 0.012). 
The changes in time in serum H-FABP levels have been pre-
sented in Fig. 1.
The serum troponin I and CK-MB levels increased at the 
6th hour and then decreased at the 24th hour in both groups, 
but the changes in serum troponin levels were statistically 
signiﬁ  cant only in group II (p = 0.017). The change in time 
in serum troponin I levels has been presented in Fig. 2.
Only 3 (3.8%) patients underwent cardiac catheteriza-
tion. None of them had speciﬁ  c coronary artery abnormali-
ties on the coronary angiography.
The relationship between serum COHb levels at 0 hour 
and serum H-FABP, troponin I and CK-MB levels at 0 hour, 
6th hour and 24th hour was assessed. No signiﬁ  cant correla-
tion was determined between serum COHb levels and CK-
MB at 0 hour, 6th hour and 24th hour (p > 0.05). A weak 
signiﬁ  cant correlation was found between the COHB levels 
and troponin I at 0 hour, (r = 0.386, p < 0.001) and H-FABP 
levels at 0 hour, 6th hour and 24th hour (for 0 hour, r = 0.227, 
p = 0.043; for the 6th hour, r = 0.312, p = 0.005; for the 24th 
hour, r = 0.407, p < 0.001). 
77 (96.2%) of the 80 patients were discharged from 
hospital after the 24-hour follow-up period and 3 (3.8%) of 
them were discharged from hospital after 48 hours.
Discussion
  
The presenting features of carbon monoxide poisoning are 
extremely vague. They include general malaise, headache, 
ﬂ  u-like symptoms, gastroenteritis, lethargy, coma, convul-
sions, arrhythmias, and pulmonary edema, and generally 
there is only limited correlation between the COHb level 
and the severity of clinical features [9]. The prognosis of the 
patients with CO intoxication is due to the injury level of 
the two vital systems, nervous and cardiovascular systems. 
While several studies have been performed on the neurologi-
cal impacts of CO poisoning and its effects on prognosis, 
recent studies have focused on cardiac injury [7, 11, 18, 
19]. Sustained myocardial injury due to CO poisoning has 
recently been demonstrated to be a signiﬁ  cant predictor of 
mortality [10].
Myocardial injury due to CO poisoning results from 
tissue hypoxia, as well as damage at cellular level. Carbon 
monoxide may bind to proteins, including myoglobin and 
cytochrome-c-oxidase. The altered mitochondrial function 
secondary to hypoxia results in temporary contractile dys-
function of myocardial cells [7]. Other mechanisms of cell 
death secondary to carbon monoxide poisoning include oxy-
gen free radical formation and subsequent lipid peroxidation 
along with induction of cellular apoptosis by nitric oxide 
secondary to high carbon monoxide levels [20]. In pre-clini-
cal models, CO poisoning in dogs results in global as well as 
relative subendocardial hypoperfusion [21]. Cardiac injury 
Figure 2. The change in time in serum troponin I levels
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at cellular level due to these probable causes appears as soon 
as contact with CO begins.  
Monitoring markers including ECG, CK, CK-MB and 
troponin is recommended for the determination and follow-
up of cardiac injury. Furthermore, echocardiography and 
coronary angiography are recommended for patients in 
whom signs of cardiac ischemia persist [7, 18]. Recent stud-
ies support the use of the new biochemical indicators such 
as H-FABP and BNP in identifying the cardiotoxicity of CO 
intoxications at an early phase [12, 18].
Human fatty acid-binding protein, a cytosolic protein 
abundantly present in myocardial tissue, plays a role in intra-
cellular fatty acid transport [13]. Human fatty acid-binding 
protein is rapidly released into the circulation when the myo-
cardium is injured. Its concentration starts to increase in 1.5 
hours in the plasma, reaches a peak in 5-6 hours, and starts 
declining at the 24th hour. H-FABP is a new and valuable di-
agnostic instrument in identifying patients with myocardial 
injury, it is more speciﬁ  c for myocardium than myoglobulin, 
and like myoglobulin, its level increases in ischemia in the 
early phase [16, 22, 23]. 
There is only one experimental and one clinical study 
on H-FABP in CO poisoning.  In a study with rats exposed 
to CO intoxication with two groups [mean COHB levels of 
47% (group A) and 67% (group B)], it was reported that the 
serum H-FABP levels increased just after the CO exposure in 
both groups [17]. Furthermore, the H-FABP level was found 
to be higher in group B than in group A, immediately after 
the exposure. However, the serum troponin I levels only in-
creased at 6 hours after the CO exposure in groups A and B. 
Similarly, we found that 70% of patients presenting to the 
Emergency Department (ED) with moderate or severe CO 
intoxication had elevated H-FABP levels, whereas 36% had 
elevated troponin I levels. H-FABP levels decreased at the 
6th and the 24th hours while troponin I and CK-MB lev-
els increased at the 6th hour and decreased at the 24th hour. 
These ﬁ  ndings suggest that in CO intoxication, cardiac in-
jury starts with exposure to CO and H-FABP can be used 
as an early marker of acute cardiac injury.  However, in our 
study, the relationship between H-FABP and the duration of 
exposure could not be assessed, as there was lack of informa-
tion on the duration and the severity of CO exposure. Further 
studies are necessary in this regard.  
It was reported that ECG changes including atrial ﬂ  utter, 
atrial ﬁ  brillation, tachycardia or ischemia can be found in CO 
intoxication, especially with carboxyhemoglobin levels of > 
20-25% [6, 7, 18]. Various rates for ECG changes have been 
reported in patients with the diagnosis of CO intoxication. 
Acikalin et al. reported that 33% of their patients displayed 
ECG changes, whereas Satran et al. found in their study at 
a center for treatment of cases with moderate to severe CO 
poisoning using hyperbaric oxygen (HBO2) therapy that 
84% of the patients had ECG changes [7, 12]. Our ﬁ  ndings 
showed that 41% of the patients had normal ECG ﬁ  ndings 
on admission to the ED, and the most common pathologi-
cal ﬁ  nding was sinus tachycardia with 48% of the patients. 
However, the patients with moderate to severe CO poisoning 
were enrolled in our study and further studies are required to 
determine the ECG change frequencies with every level of 
poisoning. 
It was found in our study that 12 out of 53 patients 
(22.6%) with the diagnosis of CO poisoning had wall mo-
tion abnormality on the echocardiograms. While there was 
no signiﬁ  cant difference between the two groups in terms of 
COHb levels, the h-FABP, troponin I and the CK-MB levels 
of these patients with wall motion abnormality on the echo-
cardiograms were found to be signiﬁ  cantly higher than that 
in patients with normal ﬁ  ndings on the echocardiograms. 
The decrease in elevation of these cardiac biomarkers was 
slower in patients with wall motion abnormality. It was re-
ported in several studies that CO intoxication causes tran-
sient wall motion abnormality and that the echocardiography 
should be part of the assessment for cardiac injury [7, 11, 
19]. The lack of a signiﬁ  cant difference in COHb levels in 
patients with and without pathology on the echocardiograms 
in our study suggests that there is no correlation between the 
COHb levels and cardiac injury. We can conclude that echo-
cardiography may provide clinical information in the follow-
up of patients with CO poisoning. However, this should be 
supported with further large-scale studies. 
One of the most critical decisions in the management 
of patients presenting to the ED with CO intoxication is to 
decide which patients should be followed-up. While the pre-
vious follow-up algorithms created according to the COHb 
levels are under discussion, recent studies have reported that 
there is a poor relationship between COHb levels and the 
clinical presentation [9, 10, 19, 24]. Our ﬁ  ndings show that 
the H-FABP levels increase earlier than other cardiac bio-
markers and that they are higher in patients with pathologi-
cal results on echocardiography compared to patients with 
normal  ﬁ  ndings on echocardiography and show a slower 
and later decrease in patients with wall motion abnormali-
ties. Again, when evaluated on a case basis, only four out 
of 80 patients (5%) in our study had higher H-FABP level 
at the 6th hour than that of at 0 hour; the troponin I levels 
of 23 patients (29%) were higher at the 6th hour than that of 
at 0 hour. The obtained data supports the use of H-FABP in 
identifying the cardiotoxicity in CO intoxications in patients 
presenting to the ED. 
It has been reported that cardiac injury in CO intoxica-
tion is global and does not cause coronary artery pathology 
[7, 11]. It was reported that high CK-MB and troponin I 
levels occurred in nearly 30% of patients with CO intoxica-
tion, although there were no obstructive lesions in the pa-
tients [11]. Despite the fact that approximately 40% of the 
80 patients in our study had high levels of troponin I and 
CK-MB, three patients with persistent ECG changes and el-
evated enzyme levels underwent coronary angiography and 
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no vascular pathology was found in these patients. This ﬁ  nd-
ing supports the probability of cardiac injury development 
in patients with normal coronary arteries following CO in-
toxication. 
Conclusion
Identiﬁ  cation of the degree of cardiac injury is important in 
patients followed-up with the diagnosis of CO intoxication. 
ECG, cardiac enzymes, and echocardiography should be 
performed in the ED on these patients to determine the level 
of injury. Measurement of the level of H-FABP, a speciﬁ  c 
indicator in identifying the cardiac injury, is useful.  
Limitations
Our study has some limitations, including the lack of follow-
up echocardiography, lack of information on the duration of 
exposure to CO, and the small number of patients with wall 
motion abnormality on echocardiography.
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